Single-Agent Topotecan as First-Line Chemotherapy in Women with Metastatic Breast Cancer: Final Results of Eastern Cooperative Oncology Group Trial E8193-Reference-Cited by-同舟云学术

Single-Agent Topotecan as First-Line Chemotherapy in Women with Metastatic Breast Cancer: Final Results of Eastern Cooperative Oncology Group Trial E8193

Published:2005-10 Issue:4 Volume:6 Page:334-339
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Wolff Antonio C.,O'Neill Anne,Kennedy M. John,Stewart James A.,Gradishar William J.,Lord Raymond S.,Davidson Nancy E.,Wood William C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study - Cancer and Leukemia Group B 8642;Costanza;J Clin Oncol,1999

2. Irinotecan pharmacogenetics: is it time to intervene?;McLeod;J Clin Oncol,2004

3. A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies;Rowinsky;J Clin Oncol,2003

4. DX-8951f, a hexacyclic camptothecin analog, on a daily-times-five schedule: a phase I and pharmacokinetic study in patients with advanced solid malignancies;Rowinsky;J Clin Oncol,2000

5. Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24- hour infusions three of every four weeks;Sharma;Clin Cancer Res,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity;International Journal of Biological Sciences;2022

2. Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases;Cancer Medicine;2020-09-03

3. Elucidation of Mechanisms of Topotecan-Induced Cell Death in Human Breast MCF-7 Cancer Cells by Gene Expression Analysis;Frontiers in Genetics;2020-07-17

4. Current Treatment Strategies in Breast Cancer Brain Metastases;Central Nervous System Metastases;2019-11-06

5. Functional daidzein enhances the anticancer effect of topotecan and reverses BCRP-mediated drug resistance in breast cancer;PHARMACOL RES;2019